Table 2

Maternal, gestational, and perinatal characteristics of the study and control groups

VariableStudy group (n=21)Control group (n=42)
If not indicated otherwise, values are mean (SD).
*Significantly different from study group.
PET, Pre-eclamptic toxaemia; PIH, pregnancy induced hypertension;
CHT, chronic hypertension; GDM, gestational diabetes mellitus;
IDDM, insulin dependent diabetes mellitus; PROM, prolonged rupture of membranes.
Mother’s age (years)27.8 (6.7)30.6 (5.4)
Jewish ethnic origin14 (66.6%)29 (69%)
Spontaneous fertilisation16 (76.2%)33 (78.6%)
Multiple births11 (52.3%)9 (21.4%)*
Maternal smoking in pregnancy03 (7.1%)
Maternal drugs during pregnancy
    MgSO42 (9.5%)1 (2.4%)
    Indomethacin1 (4.8%)1 (2.4%)
    Ritodrine01 (2.4%)
    Betamethasone2 (9.5%)7 (16.6%)
Gestational problems
    Vaginal bleeding2 (9.5%)4 (9.5%)
    PET/PIH/CHT2 (9.5%)5 (11.9%)
    GDM/IDDM03 (7.1%)
    Poly/oligohydramnion3/31/1*
    Alcohol/drug consumption00
Gestational age (weeks)35.0 (3.3)35.1 (3.4)
Birth weight (g)2352 (752)2388 (768)
Male12 (57.1%)26 (61.9%)
Non-reassuring fetal heart rate1 (4.8%)0
PROM >12 hours3 (14.3%)12 (28.5%)
Chorioamnionitis03 (7.1%)
Meconial amniotic fluids1 (4.8%)15 (35.7%)*
Mode of delivery
    Vaginal10 (47.6%)21 (50%)
    Caesarean10 (47.6%)19 (45.2%)
    Vacuum/forceps02 (4.8%)
Five minute Apgar score9.5 ± 0.69.3 ± 1
Small for gestational age3 (14.3%)7 (16.7%)
Microcephaly1 (4.8%)4 (9.6%)
Congenital malformations5 (23.8%)3 (7.1%)
Chromosomal aberrations01 (2.4%)